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Abstract 
BACKGROUND Given the well known heterogeneity of Major Depressive Disorder (MDD), 
dividing this complex disorder into subtypes is likely to be a more promising approach to identify 
its determinants than to study it as a whole. 
METHODS In a prospective population-based cohort study (CoLaus|PsyCoLaus) with 5.5 
years of follow-up, 1524 participants without MDD at baseline, aged 35 to 66 years (mean age 
51.4 years, 43.4% females), participated in the physical and psychiatric baseline and the 
psychiatric follow-up evaluations. 
RESULTS The incidence of both atypical and melancholic MDD during the follow-up period were 
predicted by female sex, a lifetime history of minor depressive disorders and higher neuroticism 
scores. Higher baseline body mass index was associated with the onset of atypical MDD, 
whereas the absence of hypertension and younger age were associated with the development of 
melancholic MDD. Unspecified MDD was predicted by younger age, low concentrations of tumor 
necrosis factor alpha and elevated life-event impact scores. 
LIMITATIONS The age range of our cohort restricts the identification of risk factors to MDD with 
onset in midlife and the recruitment in an urban area limits the generalizability of the findings.  
CONCLUSIONS Our data suggest that MDD subtypes are predicted by partially distinct 
combinations of baseline characteristics suggesting that these subtypes not only differ in their 
clinical manifestations but also in factors that contribute to their development. Subjects with 
minor depressive episodes, especially in combination with particular personality features, 
deserve close clinical attention to prevent the subsequent onset of atypical and melancholic 
major depression. 
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1. Introduction 
Major Depressive Disorder (MDD) is a complex disorder with presumably a considerable number 
of underlying, interrelated etiologic pathways (Kendler et al., 2002). Previous studies have 
suggested a large series of risk factors to be associated with the onset of MDD, including a 
positive family history of MDD (Wilde et al., 2014), female sex (Essau et al., 2010; Kendler et al., 
2004a; Mattisson et al., 2005; Palsson et al., 2001; Vinberg et al., 2013; Wang et al., 2010), 
younger age (Angst et al., 2009; Friis et al., 2002; Vinberg et al., 2013; Wang et al., 2010), lower 
socio-economic-status (SES) (Lorant et al., 2003), smoking (Luger et al., 2014), lack of physical 
activity (Mammen and Faulkner, 2013), childhood trauma (M. Li et al., 2016; Mandelli et al., 
2015) and other stressful life-events (Friis et al., 2002; Kendler et al., 1999; Kendler et al., 
2004a; Kendler et al., 2004b; Vinberg et al., 2013; Whisman and Bruce, 1999), personality 
features such as elevated neuroticism (Jeronimus et al., 2016), inadequate coping (Ormel et al., 
2004), as well as pre-existing mental conditions including dysthymic disorder (Horwath et al., 
1992; Murphy et al., 2002), minor depressive syndromes (Murphy et al., 2002), anxiety disorders 
(Beesdo et al., 2010) and substance use disorders (Brook et al., 2002; Bulloch et al., 2012). In 
addition, meta-analyses have suggested associations between MDD and the metabolic 
conditions of obesity (Luppino et al., 2010), type-II diabetes (Mezuk et al., 2008; Nouwen et al., 
2010) and the metabolic syndrome (Pan et al., 2012), although the mechanisms underlying 
these associations are still poorly understood. Finally, several studies have found inflammation 
markers such as the high sensitive C-Reactive Protein (hsCRP) or Interleukin 6 (IL-6) to be 
predictive for the onset of MDD (Khandaker et al., 2014; Pasco et al., 2010; Wium-Andersen et 
al., 2014). 
Given the heterogeneity of depression in terms of symptom manifestations, course and 
response to pharmacological treatment (Antonijevic, 2006; Ghaemi and Vohringer, 2011), the 
subtyping of depression is likely to be a promising approach to identify its determinants. Indeed, 
it has been hypothesized that depression subtypes are differently associated with biological 
mechanisms: the atypical subtype, mainly characterized by increased appetite and hypersomnia, 
could be more strongly related to the metabolic syndrome and inflammation up-regulation, 
whereas the melancholic subtype could be related to dysfunction of the hypothalamic-pituitary-
adrenal (HPA) axis (Antonijevic, 2006; Baune et al., 2012; Harald and Gordon, 2012; Kaestner 
et al., 2005; Penninx et al., 2013).  
Cross-sectional research has already provided support for associations between atypical 
depression and obesity markers (Cizza et al., 2012; Glaus et al., 2013; Lamers et al., 2013), 
diabetes (Glaus et al., 2013) or fasting glucose (Lamers et al., 2013), triglycerides (Lamers et al., 
2013; Vogelzangs et al., 2014) and the metabolic syndrome (Glaus et al., 2013; Lamers et al., 
2013; Takeuchi et al., 2013), but prospective data, which could provide clues to the direction of 
causality, are still scarce. Following a community sample over more than 5 years, we could 
demonstrate a strong prospective association between MDD with atypical features and a steeper 
increase in body-mass index (BMI) (Lasserre et al., 2014), waist circumference (Lasserre et al., 
2014), fat-mass (Lasserre et al., 2014) and fasting glucose levels (Lasserre et al., 2016). 
Similarly, a clinical cohort study conducted in the Netherlands has recently documented the 
persistence of a higher BMI, a higher prevalence and a larger number of components of the 
metabolic syndrome over six years in patients with atypical depression as compared to controls 
(Lamers et al., 2016). Although the findings of the few studies that assessed cross-sectional 
associations between depression subtypes and inflammatory markers were partially 
inconsistent, several clinical studies revealed differential associations of depression subtypes 
with inflammation markers. Chronic atypical depression was found to be associated with 
elevated levels of the CRP, IL-6 and TNF-α (Lamers, Vogelzangs, et al., 2012), whereas non-
melancholic depression has been found to be associated with increased levels of IL-1β 
(Kaestner et al., 2005). In contrast, melancholic patients did not reveal increased levels of 
inflammatory markers as compared to non-depressed individuals (Rothermundt et al., 2001). 
Similarly, a community based study (Hickman et al., 2013) and our own study (Glaus et al., 
2014) found levels of CRP to be higher in subjects suffering from atypical depression compared 
to non-atypical and non depressive subjects. To our knowledge, no previous study has yet 
prospectively assessed the risk factors for the incidence of these depression subtypes in midlife. 
Accordingly, using data from a population-based cohort study relying on semi-structured 
diagnostic interviews as well as thorough physical and biochemical investigations, the aim of the 
present study was to simultaneously assess the associations of a comprehensive array of 
potential socio-demographic, lifestyle, environmental, psychological, inflammatory and cardio-
metabolic risk factors with the incidence of the subtypes of MDD during a more than 5-year 
follow-up.  
Given cross-sectional evidence from previous studies, we hypothesized that the cardio-
metabolic risk factors BMI, diabetes and dyslipidemia as well as inflammation markers would 
potentially predict the incidence of atypical MDD but not the other MDD subtypes. In contrast, 
regarding other potential risk factors we could not formulate subtype-specific hypotheses given 
the paucity of studies that have assessed their associations with depression subtypes. 
Accordingly, based on the literature that assessed associations between these risk factors and 
MDD as a whole, we could only hypothesize that female sex, younger age, low socio-economic 
status, elevated neuroticism scores, pre-existing anxiety or substance use disorders, lack of 
physical activity, smoking and exposure to stressful life-events could predispose to the onset of 
MDD, regardless of the subtype. 
 
2. Material and methods 
2.1. Study design and sample 
The data for this article stemmed from CoLaus/PsyCoLaus (Firmann et al., 2008; Preisig et al., 
2009), a prospective cohort study designed to investigate mental disorders and cardiovascular 
risk factors in the community and to determine their associations. The sample was randomly 
selected from the 35 to 75 year-old residents of the city of Lausanne (Switzerland) from 2003 to 
2006 according to the civil register. Sixty-seven percent of the 35 to 66 year-old participants who 
underwent the physical exam (n=5535) also accepted the psychiatric evaluation (Figure 1). 
Participants with a lifetime baseline diagnosis of MDD, bipolar disorder, schizoaffective 
disorders, schizophrenia and schizophreniform disorder were excluded from the present 
analyses. Among the remaining 1993 subjects 32 died during the follow-up (mean duration 5.5 
years, s.d. 0.4 years) and 1524 accepted the psychiatric follow-up evaluation (77.7% 
participation among survivors). Non-participants at follow-up had a lower SES and were less 
likely to have relatives with MDD than participants. 
 
2.2 Measures 
Diagnostic information on mental disorders was collected at baseline and follow-up using the 
French version of the semi-structured Diagnostic Interview for Genetic Studies (DIGS) 
(Nurnberger et al., 1994; Preisig et al., 1999). The DIGS was completed with anxiety disorder 
sections of the Schedule for Affective Disorders and Schizophrenia - Lifetime Version (SADS-L) 
(Endicott and Spitzer, 1978). Psychiatric lifetime diagnoses were assigned according to the 
DSM-IV (American Psychiatric Association. Task Force on DSM-IV, 2000). Criteria for atypical 
depression features include mood reactivity and at least two of the following four symptoms: 1) 
increased appetite or significant weight gain, 2) hypersomnia, 3) leaden paralysis, and 4) 
interpersonal rejection sensitivity. The melancholic features specifier requires either a loss of 
energy or a lack of mood reactivity and three out of the following five symptoms: 1) depression 
regularly worse in the morning, 2) early morning awakening, 3) psychomotor retardation or 
agitation, 4) decreased appetite or weight loss and 5) excessive guilt. We could not take into 
account the criterion “distinct quality of depressed mood” because it was not assessed in the 
DIGS. MDD was subdivided into four subtypes according to the presence of atypical or 
melancholic features of the depressive episode that occurred during the follow-up: 1) MDD with 
atypical features only, 2) MDD with melancholic features only, 3) combined MDD with both 
atypical and melancholic features, and 4) unspecified MDD with neither atypical nor melancholic 
features. Lifetime diagnoses of depressive disorders below the threshold of MDD and dysthymic 
disorder were assigned according to the DSM-5 criteria for Other Specified Depressive 
Disorders (OSDD). The DIGS also collects information on socio-demographic characteristics 
(sex, age and SES). SES was defined according to the Hollingshead scale (Hollingshead, 1975). 
Childhood stressful life events before the age of 18 years encompassing 1) accident or severe 
catastrophe, 2) violent crime, 3) active combat or war, 4) witnessing trauma to others, and 5) 
exposure to sexual trauma, including rape, sexual abuse and exhibitionism were assessed in the 
post-traumatic stress disorder section of the DIGS. Events during adulthood were elicited using 
the life-event interview of Amiel-Lebigre (Amiel-Lebigre et al., 1984), which includes 52 
potentially stressful life-events that could occur from age 17 onwards. Participants were also 
asked to assess the impact of the event from 0 (no negative impact) to 100 (extreme negative 
impact) and the sum of all impacts of events up to the time of the baseline assessment was 
computed. 
Family history information on MDD was collected using the Family History – Research 
Diagnostic Criteria (FH-RDC) (Andreasen et al., 1977). The validity of the French version of the 
FH-RDC has previously been established through the assessment of agreement between 
diagnoses relying on family history reports and direct interviews including MDD (Vandeleur et al., 
2015). 
Participants were interviewed by master-level psychologists who were trained over a one to two-
month period. Each interview and diagnostic assignment was reviewed by an experienced 
senior psychologist. 
Neuroticism (N) was assessed using the French Eysenck Personality Questionnaire (EPQ) (H. J. 
Eysenck and Eysenck, 1975). The originator of this instrument reported Cronbach’s α 
coefficients of 0.78 to 0.87 for Neuroticism using three different French samples (H. J. Eysenck, 
Eysenck, S.B.G., Gauquelin, M., Gauquelin, F., Pascal C., Pascal, D., 1980) 
Coping strategies were evaluated using the French version (Bodmer and Grob, 1996) of the 
coping section of the Euronet questionnaire (Grob et al., 1993), which includes the factors 
Emotion-focused coping, Help-seeking behaviors, and Problem-focused coping according to 
principal component analysis (Perrin et al., 2014). The standardized Cronbach’s α coefficients 
for these dimensions were 0.65, 0.69 and 0.44, respectively (Perrin et al., 2014). As emotion-
focused coping was highly correlated with neuroticism (r=0.63; p<.0001) we could not include it 
in our analyses. 
Physical measures taken at baseline are described in detail elsewhere (Firmann et al., 2008). 
The assessment included weight, height and blood pressure as well as venous blood samples to 
determine body mass index (BMI) and the levels of glucose, HDL-cholesterol, LDL-cholesterol, 
triglycerides, Interleukin 1β (IL-1β), IL-6, Tumor Necrosis Factor – α (TNF-α) and hsCRP. Hs-
CRP was assessed using immunoassay and latex HS (IMMULITE 1000-High, Diagnostic 
Products Corporation, LA, CA, USA), with maximum intra- and interbatch coefficients of variation 
of 1.3% and 4.6%, respectively (Firmann et al., 2008). For cytokine and adipokine 
measurements, serum samples were stored at -80°C before assessment and sent on dry ice to 
the laboratory. Cytokine concentrations were measured using a multiplexed particle-based flow 
cytometric cytokine assay (Marques-Vidal et al., 2011). Lower detection limits (LOD) for 
interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were 0.2 pg/ml. 
For concentrations below the LOD (37.5% for IL-1β, 8.2% for IL-6, 0.7% for TNF-α), a value of 
0.1 pg/ml was assigned. Good agreement between signal and cytokine was found within the 
assay range (R2≥0.99). Intra and inter-assay coefficients of variation were 15% and 16.7% for 
IL-1β, 16.9% and 16.1% for IL-6 and 12.5% and 13.5% for TNF-α, respectively. Repeated 
measurements were conducted in 80 subjects randomly drawn from the initial sample; 
Spearman rank correlations between duplicate measurements were 0.914, 0.961 and 0.891 for 
IL-1β, IL-6 and TNF-α (all p<0.001). A diagnosis of hypertension was assigned in the case of 
systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg, or if drug 
treatment was prescribed for hypertension. Diabetes was diagnosed when fasting blood glucose 
≥7 mmol/l was measured or when the subject was treated for diabetes. Diagnostic criteria for 
dyslipidemia were: HDL-cholesterol <1 mmol/l, or LDL-cholesterol ≥4.1 mmol/l, or triglycerides 
≥2.2 mmol/l, or when treated with a lipid-lowering drug. 
Information on smoking and physical activity was collected through a standardized interview. 
Nicotine consumption entailed a current daily consumption of at least 10 cigarettes for at least 2 
months. Participants were considered to be physically inactive if they reported engaging in 
physical activity for less than 20 minutes twice a week. 
The Institutional Ethics Committee of the University of Lausanne approved the CoLaus and the 
PsyCoLaus study. All participants signed a written informed consent form after having received a 
detailed description of the goal and funding of the study. 
 
2.3 Statistical Analysis 
Analyses were performed using the Statistical Analysis System (SAS) version 9.3 for Windows. 
Multiple imputations were used for missing data. Using the Markov Chain Monte Carlo with 
noninformative Jeffreys prior (proc mi), 10000 complete datasets were created, analyzed 
separately and then combined according to Rubin’s multiple imputation strategy. Marginal 
comparisons between baseline characteristics and depression status at follow-up were 
performed using chi-square tests of independence and ANOVA wherever appropriate. 
Multinomial logistic regression was then used to simultaneously assess the potential effect of 
these baseline characteristics on the incidence of MDD subtypes during the follow-up (proc 
logistic). Adult life-event impact scores as well as levels of cytokine and hsCRP concentrations 
were log-transformed. Continuous variables were standardized in order to obtain comparable 
sizes of odd’s ratios for all exposure variables. 
 
3. Results 
During the follow-up 31 of the subjects (2.03%) developed MDD with atypical features, 43 MDD 
with melancholic features (2.82%), 20 MDD with both atypical and melancholic features (1.31%) 
and 98 MDD with unspecified features (6.43%). Given the limited number of subjects that 
developed combined MDD (n=20) and because none of them were exposed to childhood events 
or dysthymia, we could not include them into our multinomial logistic regression model. 
Table 1 presents the description of the whole sample and the subgroups according to the MDD 
status at follow-up. Significant inter-group differences were found for sex, age, the presence of 
pre-existing OSDD, anxiety disorders and hypertension as well as for the adult life-event impact 
and neuroticism scores. There were more women among subjects who developed a first major 
depressive episode during follow-up, as compared to those who did not develop MDD, 
regardless of the depression subtype. Those who developed melancholic MDD were younger at 
baseline than those who developed either atypical or no MDD. Similarly, subjects who 
developed unspecified MDD were younger than those who did not develop MDD. Moreover, 
both subjects who developed atypical and those who developed melancholic MDD reported a 
lifetime history of OSDD at baseline more frequently than those who did not develop MDD. 
Subjects who developed atypical or melancholic MDD reported lifetime anxiety disorders at 
baseline more frequently than those who developed either unspecified MDD or no MDD. Those 
with melancholic or unspecified MDD also reported hypertension less frequently at baseline than 
those who did not develop MDD. In addition, subjects with unspecified MDD revealed a higher 
baseline adult life-event impact score than those who did not develop MDD. Finally, subjects 
who developed MDD, regardless of the subtype, scored higher on neuroticism at baseline than 
those who did not develop MDD; those with melancholic MDD also scored higher on neuroticism 
than those with unspecified MDD.  
Table 2 provides the results of the multinomial logistic regression analysis which simultaneously 
included all baseline variables into one model. Women as well as subjects with a lifetime history 
of OSDD, with a higher BMI and a higher neuroticism score at baseline were more likely to 
develop a first major depressive episode with atypical features during the follow-up. Female sex, 
a lifetime history of OSDD and a higher baseline neuroticism score also predicted the onset of 
melancholic MDD. In addition, younger age was associated with the development of melancholic 
MDD, whereas hypertension decreased the likelihood of the occurrence of this MDD subtype. 
Finally, being of younger age, having lower TNF-α concentrations and a higher life-event impact 
score at baseline predicted the onset of unspecified MDD during follow-up. 
 
4. Discussion 
To our knowledge, this is the first study to prospectively assess a wide array of potential 
predictors of the incidence of MDD subtypes in midlife. Our major finding is that the three MDD 
subtypes are predicted by partially distinct combinations of baseline characteristics suggesting 
that these subtypes not only differ in their clinical manifestations but also in factors that 
contribute to their development. Although atypical and melancholic MDD share female sex, pre-
existing OSDD and elevated scores on neuroticism at baseline as common risk factors, they 
revealed opposite associations with cardio-metabolic characteristics. Indeed, the incidence of 
atypical MDD was associated with elevated BMI, whereas the incidence of melancholic MDD 
was negatively associated with hypertension at baseline. In contrast to atypical and melancholic 
MDD, the incidence of unspecified MDD was essentially associated with a high life-event impact 
score at baseline and a low concentration of TNF-α. 
In line with previous research (Piccinelli and Wilkinson, 2000) we found a strong association 
between female sex and MDD, but in contrast to studies that supported a particularly high 
predominance of women in atypical depression (Angst et al., 2007; Blanco et al., 2012), we did 
not observe significant sex differences across MDD subtypes. We also observed that younger 
age was predictive for the onset of both melancholic and unspecified MDD which is consistent 
with observations of higher prevalence of MDD in younger cohorts in the community (Kessler et 
al., 1994). 
Unlike unspecified MDD, the onset of both atypical and melancholic MDD was associated with 
preexisting OSDD, which corroborates findings from previous prospective studies that showed 
subthreshold depressive episodes to be a risk factor for the subsequent development of MDD as 
a whole (Forsell, 2007; Horwath et al., 1992). In contrast to previous studies (Beesdo et al., 
2010; Brook et al., 2002; Bulloch et al., 2012), neither anxiety nor substance use disorders were 
predictors of the onset of MDD subtypes in our study, which could be due to the higher age of 
our cohort at baseline. Moreover, the discrepant results with respect to the NESDA study, which 
revealed a significant cross-sectional association between anxiety disorders and the atypical or 
melancholic depression subtypes (Lamers et al., 2016), could be attributable to the higher 
degree of severity of depressed patients in the clinical NESDA study as compared to those in 
our population-based sample. In addition, depression subtype diagnoses were assigned 
according to different procedures in the two studies. In the NESDA study the assignment relied 
on latent class analysis, whereas in our study DSM-IV specifier criteria were applied.  
The observed prospective association between BMI at baseline and the onset of atypical MDD 
confirms previous cross-sectional findings of strong links between this MDD subtype and 
overweight or obesity (Cizza et al., 2012; Glaus et al., 2013; Kendler et al., 1996; Lamers et al., 
2013; Y. Li et al., 2014; Sullivan et al., 2002). Moreover, in a previous article (Lasserre et al., 
2014) we could show that this MDD subtype is a predictor of a steeper increase of obesity 
markers during the 5.5-year follow-up period, whereas the present finding also supports an 
inverse association. Such a bidirectional relationship is compatible with two meta-analyses for 
MDD as a whole (Luppino et al., 2010), and the results of a recent genetic study that revealed 
an association between polygenic risk scores of BMI and atypical depression (Milaneschi et al., 
2015), suggesting shared genetic liability. In contrast, a study relying on Mendelian 
randomization analysis did not support a causal relationship between elevated BMI and the risk 
of MDD as a whole (Hung et al., 2014), which however could be due to the heterogeneity of 
MDD. Indeed, according to our data the magnitude of the association with BMI varies largely 
across MDD subtypes. Among the other cardio-metabolic factors, hypertension was associated 
with the incidence of melancholic MDD, but as a protective factor. This finding is in line with the 
results of Lamers et al. (Lamers et al., 2013), who also documented lower blood pressure 
among melancholic subjects compared to controls. It has been hypothesized that low blood 
pressure leads to depression through somatic symptoms and fatigue (Licht et al., 2009). 
Alternatively, altered levels of neuropeptides such as the neuropeptide Y could be involved in 
depression and suppress sympathetic activity resulting in decreased blood pressure (Licht et al., 
2009). In contrast to the BMI, diabetes was not a predictor of atypical MDD in our study and the 
previously reported cross-sectional association between diabetes and this MDD subtype may 
rather be explained by an opposite causal link given our recent observation of a significant 
longitudinal association between atypical MDD at baseline and a steeper increase of the fasting 
glucose level during the follow up (Lasserre et al., 2016). 
Regarding inflammatory markers, we observed a significant association between a low baseline 
TNF-α concentration and the incidence of unspecified MDD, and a similar association with a 
trend towards statistical significance (OR=0.82, p=0.094) that emerged for lower CRP levels. 
These findings may suggest that higher inflammatory activity at baseline is rather protective, as 
it was associated with a lower risk of unspecified MDD. However, given the anti-inflammatory 
effects of cortisol (Sternberg, 2006) and catecholamines (Elenkov et al., 2005), the low 
inflammatory marker concentrations at baseline in subjects who developed unspecified MDD 
during the follow-up could also be attributable to activation of their HPA axis and sympathetic 
nervous system as a consequence of elevated life-event stress reported by these subjects at 
baseline. A cross-sectional association between higher cortisol and lower inflammation marker 
levels was previously demonstrated for instance by Lamers et al. (Lamers et al., 2013). Although 
both IL-6 and IL-1β were significantly associated with TNF-α baseline levels in our study, their 
baseline levels showed no significant associations with unspecified MDD at follow-up. This could 
be due to the lack of reliable plasma measures for IL-1β, as was recently discussed (Ridker, 
2016), and anti-inflammatory properties of IL-6, which activates the HPA axis to secrete cortisol 
in the context of stress (Elenkov et al., 2005). Therefore, in the above scenario, an increase in 
IL-6 would have been more expected than a decrease. However, we acknowledge that the 
proposed complex neuroendocrine and immune interactions in the context of life-event stress at 
baseline predicting unspecified MDD at follow-up must remain speculative. Particularly so, as we 
had no baseline cortisol and catecholamine measures available to further test this hypothesis, 
including the temporal dynamics in these parameters. 
Our analyses also revealed associations between high neuroticism scores at baseline and the 
onset of both atypical and melancholic MDD during the follow-up, which is consistent with the 
findings of the NESDA study (Lamers et al., 2010; Lamers, Rhebergen, et al., 2012) as well as 
with a recent meta-analysis showing elevated neuroticism to predispose to MDD as a whole 
(Jeronimus et al., 2016). Moreover, a recent genetic study found the polygenic risk score of 
neuroticism, derived from GWAS meta-analysis, to significantly predict MDD indicating either a 
causal relationship between neuroticism and MDD or underlying shared liability (Smith et al., 
2016). However, our finding regarding the predictive effect of neuroticism needs to be taken with 
caution given that some subjects may have been unable to recall remote depressive episodes, 
which could have resulted in both elevated neuroticism scores and an increased risk of new 
depressive episodes.  
In contrast to several previous studies (M. Li et al., 2016; Mandelli et al., 2015) we did not find 
childhood events to predict any of the MDD subtypes, which could be due to the relatively old 
age of our cohort. Indeed, subjects with childhood trauma were likely to have already developed 
MDD before the age at study intake and were therefore excluded from the present analyses, 
whereas those who did not develop depression prior to baseline despite such trauma were likely 
to be resilient. The perceived impact of adult life-events was exclusively associated with the 
onset of unspecified MDD. Given that the subjects who developed this MDD subtype did not 
differ from those who developed atypical or melancholic MDD with respect to the adult life-event 
impact score at baseline, the onset of depressive episodes in these subjects could be 
attributable to both a higher level of perceived stress as well as reduced stress tolerance. The 
two mechanisms have been suggested as a risk factor for MDD as a whole (Hammen, 2005). 
Unlike the other MDD subtypes, the onset of unspecified MDD was not associated with pre-
existing psychiatric disorders, cardio-metabolic conditions or elevated neuroticism scores.  
The lack of association between the family history of depression and MDD subtypes in our 
study, which contrasts with meta-analytical findings (Wilde et al., 2014), could be attributable to 
the advanced age of our cohort. Indeed MDD with an onset after age 35 may be less determined 
by genetic and factors related to the family of origin than depression that occurs earlier in life 
(Valkanova and Ebmeier, 2013). In addition, specific MDD subtypes may be better predicted by 
a family history of the same MDD subtype than by MDD as a whole. Unfortunately, our family 
history information did not allow for the subtyping of MDD in first-degree relatives.  
The results of the present study should be considered in the context of several limitations. First, 
the age range of our cohort does not cover the main risk period for the onset of MDD. Indeed, 
surveys conducted in the community revealed that more than 50% of MDD start before the age 
of 32 years (Kessler et al., 2005). For this reason our findings may not be generalizable to 
subjects younger than 35 years of age. Second, given the mean age of our cohort it is possible 
that subjects did not recall remote episodes and hence risk factors for recurrence could have 
been confounded with risk factors for the incidence of MDD subtypes. Third, despite a large 
cohort, the number of subjects who developed a specific subtype of MDD was still rather low 
which diminished the statistical power to detect significant predictors of the onset of each MDD 
category and did not allow us to determine the risk factors for combined MDD given the low 
number of subjects who developed this outcome. Fourth, our analyses focused on the factors 
predicting the onset and type of the first depressive episode, which does not need to be followed 
by the same type of episode over time. As a subject can switch across MDD subtypes over 
lifetime, the factors predicting the first episode are not necessarily identical with those predicting 
the final MDD subtype diagnosis over lifetime. Moreover, our diagnostic instrument only 
assessed the full range of symptoms for one depressive episode during the follow-up, whereas 
11.6% of subjects revealed more than one episode and could potentially be misclassified. Fifth, 
data were based on an urban sample in Switzerland which may not be representative of the 
general population. However, it is unlikely that the specific characteristics of this sample 
significantly affected the assessed prospective associations. Sixth, we could not test whether the 
HPA axis functioning is differentially associated with the melancholic and atypical MDD subtypes 
(Harald and Gordon, 2012) as no cortisol measure of stress was available at baseline. Seventh, 
given that subjects with low SES or a family history of MDD at baseline were less likely to 
participate it is possible that we have underestimated the effect of these potential risk factors on 
the outcomes. This would have been the case if, among subjects exposed to one of these two 
potential risk factors, those who developed MDD subtypes were more likely to refuse 
participation than those who did not develop MDD subtypes.  
In conclusion, the findings of this study have important clinical and scientific implications. Our 
data suggest that demographic and cardio-metabolic characteristics, inflammatory marker levels, 
life stressors and psychological factors differentially predict the incidence of MDD subtypes in 
midlife, which further highlights the need of subtyping the heterogeneous category of MDD. 
Moreover, they further suggest that minor depressive disorders, especially in combination with 
particular personality features, deserve close clinical attention in order to prevent the subsequent 
onset of the atypical and melancholic depression subtypes. In the last years, algorithms 
designed to predict the onset of MDD as a whole have led to the development of personalized 
prevention strategies based on the both the level and the profile of risk for an individual (King et 
al., 2008). Our finding of differential risk profiles for MDD subtypes could contribute to refining 
such personalized prevention strategies by shifting them from a general MDD prevention to a 
more specific prevention of MDD subtypes. However, our results derived from a midlife sample 
first need to be confirmed by longitudinal studies that ideally follow subjects from adolescence 
on and by genetic research based on Mendelian randomization, which could provide additional 
clues to the complex interplay between MDD subtypes and personality or metabolic traits. 
  
Acknowledgments 
The authors would like to express their sincere gratitude to the participants of the study and to the 
colleagues who contributed to data collection and management of the study.  
Role of the funding source 
The CoLaus|PsyCoLaus study was and is supported by research grants from GlaxoSmithKline, the 
Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (grants 
3200B0–105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468 and 33CS30-148401). 
 
  
References 
American Psychiatric Association. Task Force on DSM-IV. 2000. DSM-IV-TR : diagnostic and statistical 
manual of mental disorders (4th ed, text revision ed.). Washington, DC: American Psychiatric 
Association. 
Amiel-Lebigre, F.,  Pelc, I., Lagorce, A. 1984. Evénements existentiels et dépression. Une étude 
comparative de plusieurs types de déprimés (Existential events and depression. A comparative 
study of several types of depressions). Ann médico-psychol, 142, 937-958.  
Andreasen, N. C.,  Endicott, J.,  Spitzer, R. L., Winokur, G. 1977. The family history method using 
diagnostic criteria: Reliability and validity. Arch Gen Psychiatry, 34, 1229-1235.  
Angst, J.,  Gamma, A.,  Benazzi, F.,  Ajdacic, V., Rossler, W. 2007. Melancholia and atypical depression in 
the Zurich study: epidemiology, clinical characteristics, course, comorbidity and personality. Acta 
Psychiatr Scand Suppl, 72-84. doi:10.1111/j.1600-0447.2007.00965.x 
Angst, J.,  Gamma, A.,  Rossler, W.,  Ajdacic, V., Klein, D. N. 2009. Long-term depression versus episodic 
major depression: results from the prospective Zurich study of a community sample. J Affect 
Disord, 115, 112-121. doi:10.1016/j.jad.2008.09.023 
Antonijevic, I. A. 2006. Depressive disorders -- is it time to endorse different pathophysiologies? 
Psychoneuroendocrinology, 31, 1-15. doi:10.1016/j.psyneuen.2005.04.004 
Baune, B. T.,  Stuart, M.,  Gilmour, A.,  Wersching, H.,  Heindel, W.,  Arolt, V., Berger, K. 2012. The 
relationship between subtypes of depression and cardiovascular disease: a systematic review of 
biological models. Transl Psychiatry, 2, e92. doi:10.1038/tp.2012.18 
Beesdo, K.,  Pine, D. S.,  Lieb, R., Wittchen, H. U. 2010. Incidence and risk patterns of anxiety and 
depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry, 67, 
47-57. doi:10.1001/archgenpsychiatry.2009.177 
Blanco, C.,  Vesga-Lopez, O.,  Stewart, J. W.,  Liu, S. M.,  Grant, B. F., Hasin, D. S. 2012. Epidemiology of 
major depression with atypical features: results from the National Epidemiologic Survey on 
Alcohol and Related Conditions (NESARC). J Clin Psychiatry, 73, 224-232. 
doi:10.4088/JCP.10m06227 
Bodmer, N. M., Grob, A. 1996. Bien-être et contraintes d'adolescents: une comparaison entre 
adolescents de familles monoparentales et de familles biparentales (well-being and constraints 
of adolescents: A comparison of adolescents from single-parent and two-parent families). J Int 
de Psychologie, 31, 39-48.  
Brook, D. W.,  Brook, J. S.,  Zhang, C.,  Cohen, P., Whiteman, M. 2002. Drug use and the risk of major 
depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry, 59, 
1039-1044.  
Bulloch, A.,  Lavorato, D.,  Williams, J., Patten, S. 2012. Alcohol consumption and major depression in the 
general population: the critical importance of dependence. Depress Anxiety, 29, 1058-1064. 
doi:10.1002/da.22001 
Cizza, G.,  Ronsaville, D. S.,  Kleitz, H.,  Eskandari, F.,  Mistry, S.,  Torvik, S.,  Sonbolian, N.,  Reynolds, J. C.,  
Blackman, M. R.,  Gold, P. W.,  Martinez, P. E., Group, P. O. W. E. R. S. 2012. Clinical subtypes of 
depression are associated with specific metabolic parameters and circadian endocrine profiles in 
women: the power study. PLoS One, 7, e28912. doi:10.1371/journal.pone.0028912 
Elenkov, I. J.,  Iezzoni, D. G.,  Daly, A.,  Harris, A. G., Chrousos, G. P. 2005. Cytokine dysregulation, 
inflammation and well-being. Neuroimmunomodulation, 12, 255-269. doi:10.1159/000087104 
Endicott, J., Spitzer, R. L. 1978. A diagnostic interview: the schedule for affective disorders and 
schizophrenia. Archives of General Psychiatry, 35, 837-844.  
Essau, C. A.,  Lewinsohn, P. M.,  Seeley, J. R., Sasagawa, S. 2010. Gender differences in the developmental 
course of depression. J Affect Disord, 127, 185-190. doi:10.1016/j.jad.2010.05.016 
Eysenck, H. J., Eysenck, S. B. G. 1975. Manual of the Eysenck Personality Questionnaire. London: Hodder 
& Stoughton Educational. 
Eysenck, H. J., Eysenck, S.B.G., Gauquelin, M., Gauquelin, F., Pascal C., Pascal, D. 1980. The structure of 
the personality among French compared to that of an English: cross-cultural comparison (Vol. 1-
2). 
Firmann, M.,  Mayor, V.,  Vidal, P. M.,  Bochud, M.,  Pecoud, A.,  Hayoz, D.,  Paccaud, F.,  Preisig, M.,  
Song, K. S.,  Yuan, X.,  Danoff, T. M.,  Stirnadel, H. A.,  Waterworth, D.,  Mooser, V.,  Waeber, G., 
Vollenweider, P. 2008. The CoLaus study: a population-based study to investigate the 
epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. 
BMC Cardiovasc Disord, 8, 6. doi:10.1186/1471-2261-8-6 
Forsell, Y. 2007. A three-year follow-up of major depression, dysthymia, minor depression and 
subsyndromal depression: results from a population-based study. Depress Anxiety, 24, 62-65. 
doi:10.1002/da.20231 
Friis, R. H.,  Wittchen, H. U.,  Pfister, H., Lieb, R. 2002. Life events and changes in the course of depression 
in young adults. Eur Psychiatry, 17, 241-253.  
Ghaemi, S. N., Vohringer, P. A. 2011. The heterogeneity of depression: an old debate renewed. Acta 
Psychiatr Scand, 124, 497. doi:10.1111/j.1600-0447.2011.01746.x 
Glaus, J.,  Vandeleur, C.,  Gholam-Rezaee, M.,  Castelao, E.,  Perrin, M.,  Rothen, S.,  Bovet, P.,  Marques-
Vidal, P.,  von Kanel, R.,  Merikangas, K.,  Mooser, V.,  Waterworth, D. M.,  Waeber, G.,  
Vollenweider, P., Preisig, M. 2013. Atypical depression and alcohol misuse are related to the 
cardiovascular risk in the general population. Acta Psychiatr Scand, 128, 282-293. 
doi:10.1111/acps.12057 
Glaus, J.,  Vandeleur, C. L.,  von Kanel, R.,  Lasserre, A. M.,  Strippoli, M. P.,  Gholam-Rezaee, M.,  
Castelao, E.,  Marques-Vidal, P.,  Bovet, P.,  Merikangas, K.,  Mooser, V.,  Waeber, G.,  
Vollenweider, P.,  Aubry, J. M., Preisig, M. 2014. Associations between mood, anxiety or 
substance use disorders and inflammatory markers after adjustment for multiple covariates in a 
population-based study. J Psychiatr Res, 58, 36-45. doi:10.1016/j.jpsychires.2014.07.012 
Grob, A.,  Bodmer, N. M., Flammer, A. 1993. Living conditions in Europe: the case of Switzerland. 
University of Bern: Institue of Psychology. 
Hammen, C. 2005. Stress and depression. Annu Rev Clin Psychol, 1, 293-319. 
doi:10.1146/annurev.clinpsy.1.102803.143938 
Harald, B., Gordon, P. 2012. Meta-review of depressive subtyping models. J Affect Disord, 139, 126-140. 
doi:10.1016/j.jad.2011.07.015 
Hickman, R. J.,  Khambaty, T., Stewart, J. C. 2013. C-reactive protein is elevated in atypical but not 
nonatypical depression: data from the National Health and Nutrition Examination Survey 
(NHANES) 1999-2004. J Behav Med. doi:10.1007/s10865-013-9510-0 
Hollingshead, A. B. (1975). [Four factor Index of Social Status]. 
Horwath, E.,  Johnson, J.,  Klerman, G. L., Weissman, M. M. 1992. Depressive symptoms as relative and 
attributable risk factors for first-onset major depression. Arch Gen Psychiatry, 49, 817-823.  
Hung, C. F.,  Rivera, M.,  Craddock, N.,  Owen, M. J.,  Gill, M.,  Korszun, A.,  Maier, W.,  Mors, O.,  Preisig, 
M.,  Rice, J. P.,  Rietschel, M.,  Jones, L.,  Middleton, L.,  Aitchison, K. J.,  Davis, O. S.,  Breen, G.,  
Lewis, C.,  Farmer, A., McGuffin, P. 2014. Relationship between obesity and the risk of clinically 
significant depression: Mendelian randomisation study. Br J Psychiatry, 205, 24-28. 
doi:10.1192/bjp.bp.113.130419 
Jeronimus, B. F.,  Kotov, R.,  Riese, H., Ormel, J. 2016. Neuroticism's prospective association with mental 
disorders halves after adjustment for baseline symptoms and psychiatric history, but the 
adjusted association hardly decays with time: a meta-analysis on 59 longitudinal/prospective 
studies with 443 313 participants. Psychological Medicine, 46, 2883-2906. 
doi:10.1017/S0033291716001653 
Kaestner, F.,  Hettich, M.,  Peters, M.,  Sibrowski, W.,  Hetzel, G.,  Ponath, G.,  Arolt, V.,  Cassens, U., 
Rothermundt, M. 2005. Different activation patterns of proinflammatory cytokines in 
melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect 
Disord, 87, 305-311. doi:10.1016/j.jad.2005.03.012 
Kendler, K. S.,  Eaves, L. J.,  Walters, E. E.,  Neale, M. C.,  Heath, A. C., Kessler, R. C. 1996. The 
identification and validation of distinct depressive syndromes in a population-based sample of 
female twins. Arch Gen Psychiatry, 53, 391-399.  
Kendler, K. S.,  Gardner, C. O., Prescott, C. A. 2002. Toward a comprehensive developmental model for 
major depression in women. Am J Psychiatry, 159, 1133-1145. doi:10.1176/appi.ajp.159.7.1133 
Kendler, K. S.,  Karkowski, L. M., Prescott, C. A. 1999. Causal relationship between stressful life events 
and the onset of major depression. Am J Psychiatry, 156, 837-841.  
Kendler, K. S.,  Kuhn, J., Prescott, C. A. 2004a. The interrelationship of neuroticism, sex, and stressful life 
events in the prediction of episodes of major depression. Am J Psychiatry, 161, 631-636.  
Kendler, K. S.,  Kuhn, J. W., Prescott, C. A. 2004b. Childhood sexual abuse, stressful life events and risk for 
major depression in women. Psychol Med, 34, 1475-1482.  
Kessler, R. C.,  Berglund, P.,  Demler, O.,  Jin, R.,  Merikangas, K. R., Walters, E. E. 2005. Lifetime 
prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity 
Survey Replication. Arch Gen Psychiatry, 62, 593-602. doi:10.1001/archpsyc.62.6.593 
Kessler, R. C.,  Mcgonagle, K. A.,  Zhao, S. Y.,  Nelson, C. B.,  Hughes, M.,  Eshleman, S.,  Wittchen, H. U., 
Kendler, K. S. 1994. Lifetime and 12-Month Prevalence of Dsm-Iii-R Psychiatric-Disorders in the 
United-States - Results from the National-Comorbidity-Survey. Archives of General Psychiatry, 
51, 8-19.  
Khandaker, G. M.,  Pearson, R. M.,  Zammit, S.,  Lewis, G., Jones, P. B. 2014. Association of serum 
interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult 
life: a population-based longitudinal study. JAMA Psychiatry, 71, 1121-1128. 
doi:10.1001/jamapsychiatry.2014.1332 
King, M.,  Walker, C.,  Levy, G.,  Bottomley, C.,  Royston, P.,  Weich, S.,  Bellon-Saameno, J. A.,  Moreno, 
B.,  Svab, I.,  Rotar, D.,  Rifel, J.,  Maaroos, H. I.,  Aluoja, A.,  Kalda, R.,  Neeleman, J.,  Geerlings, M. 
I.,  Xavier, M.,  Carraca, I.,  Goncalves-Pereira, M.,  Vicente, B.,  Saldivia, S.,  Melipillan, R.,  Torres-
Gonzalez, F., Nazareth, I. 2008. Development and validation of an international risk prediction 
algorithm for episodes of major depression in general practice attendees: the PredictD study. 
Arch Gen Psychiatry, 65, 1368-1376. doi:10.1001/archpsyc.65.12.1368 
Lamers, F.,  Beekman, A. T.,  van Hemert, A. M.,  Schoevers, R. A., Penninx, B. W. 2016. Six-year 
longitudinal course and outcomes of subtypes of depression. Br J Psychiatry, 208, 62-68. 
doi:10.1192/bjp.bp.114.153098 
Lamers, F.,  de Jonge, P.,  Nolen, W. A.,  Smit, J. H.,  Zitman, F. G.,  Beekman, A. T., Penninx, B. W. 2010. 
Identifying depressive subtypes in a large cohort study: results from the Netherlands Study of 
Depression and Anxiety (NESDA). J Clin Psychiatry, 71, 1582-1589. doi:10.4088/JCP.09m05398blu 
Lamers, F.,  Rhebergen, D.,  Merikangas, K. R.,  de Jonge, P.,  Beekman, A. T., Penninx, B. W. 2012. 
Stability and transitions of depressive subtypes over a 2-year follow-up. Psychol Med, 42, 2083-
2093. doi:10.1017/S0033291712000141 
Lamers, F.,  Vogelzangs, N.,  Merikangas, K. R.,  de Jonge, P.,  Beekman, A. T., Penninx, B. W. 2012. 
Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in 
melancholic versus atypical depression. Mol Psychiatry, 10.1038/mp.2012.144, Epub. 
doi:10.1038/mp.2012.144 
Lamers, F.,  Vogelzangs, N.,  Merikangas, K. R.,  de Jonge, P.,  Beekman, A. T., Penninx, B. W. 2013. 
Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in 
melancholic versus atypical depression. Mol Psychiatry, 18, 692-699. doi:10.1038/mp.2012.144 
Lasserre, A. M.,  Glaus, J.,  Vandeleur, C. L.,  Marques-Vidal, P.,  Vaucher, J.,  Bastardot, F.,  Waeber, G.,  
Vollenweider, P., Preisig, M. 2014. Depression with atypical features and increase in obesity, 
body mass index, waist circumference, and fat mass: a prospective, population-based study. 
JAMA Psychiatry, 71, 880-888. doi:10.1001/jamapsychiatry.2014.411 
Lasserre, A. M.,  Strippoli, M. F.,  Glaus, J.,  Gholam-Rezaee, M.,  Vandeleur, C. L.,  Castelao, E.,  Marques-
Vidal, P.,  Waeber, G.,  Vollenweider, P., Preisig, M. 2016. Prospective associations of depression 
subtypes with cardio-metabolic risk factors in the general population. Mol Psychiatry. 
doi:10.1038/mp.2016.178 
Li, M.,  D'Arcy, C., Meng, X. 2016. Maltreatment in childhood substantially increases the risk of adult 
depression and anxiety in prospective cohort studies: systematic review, meta-analysis, and 
proportional attributable fractions. Psychol Med, 46, 717-730. doi:10.1017/S0033291715002743 
Li, Y.,  Aggen, S.,  Shi, S.,  Gao, J.,  Li, Y.,  Tao, M.,  Zhang, K.,  Wang, X.,  Gao, C.,  Yang, L.,  Liu, Y.,  Li, K.,  
Shi, J.,  Wang, G.,  Liu, L.,  Zhang, J.,  Du, B.,  Jiang, G.,  Shen, J.,  Zhang, Z.,  Liang, W.,  Sun, J.,  Hu, 
J.,  Liu, T.,  Wang, X.,  Miao, G.,  Meng, H.,  Li, Y.,  Hu, C.,  Li, Y.,  Huang, G.,  Li, G.,  Ha, B.,  Deng, 
H.,  Mei, Q.,  Zhong, H.,  Gao, S.,  Sang, H.,  Zhang, Y.,  Fang, X.,  Yu, F.,  Yang, D.,  Liu, T.,  Chen, Y.,  
Hong, X.,  Wu, W.,  Chen, G.,  Cai, M.,  Song, Y.,  Pan, J.,  Dong, J.,  Pan, R.,  Zhang, W.,  Shen, Z.,  
Liu, Z.,  Gu, D.,  Wang, X.,  Liu, X.,  Zhang, Q.,  Flint, J., Kendler, K. S. 2014. Subtypes of major 
depression: latent class analysis in depressed Han Chinese women. Psychol Med, 44, 3275-3288. 
doi:10.1017/S0033291714000749 
Licht, C. M.,  de Geus, E. J.,  Seldenrijk, A.,  van Hout, H. P.,  Zitman, F. G.,  van Dyck, R., Penninx, B. W. 
2009. Depression is associated with decreased blood pressure, but antidepressant use increases 
the risk for hypertension. Hypertension, 53, 631-638. 
doi:10.1161/HYPERTENSIONAHA.108.126698 
Lorant, V.,  Deliege, D.,  Eaton, W.,  Robert, A.,  Philippot, P., Ansseau, M. 2003. Socioeconomic 
inequalities in depression: a meta-analysis. Am J Epidemiol, 157, 98-112.  
Luger, T. M.,  Suls, J., Vander Weg, M. W. 2014. How robust is the association between smoking and 
depression in adults? A meta-analysis using linear mixed-effects models. Addict Behav, 39, 1418-
1429. doi:10.1016/j.addbeh.2014.05.011 
Luppino, F. S.,  de Wit, L. M.,  Bouvy, P. F.,  Stijnen, T.,  Cuijpers, P.,  Penninx, B. W., Zitman, F. G. 2010. 
Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal 
studies. Arch Gen Psychiatry, 67, 220-229. doi:10.1001/archgenpsychiatry.2010.2 
Mammen, G., Faulkner, G. 2013. Physical activity and the prevention of depression: a systematic review 
of prospective studies. Am J Prev Med, 45, 649-657. doi:10.1016/j.amepre.2013.08.001 
Mandelli, L.,  Petrelli, C., Serretti, A. 2015. The role of specific early trauma in adult depression: A meta-
analysis of published literature. Childhood trauma and adult depression. Eur Psychiatry, 30, 665-
680. doi:10.1016/j.eurpsy.2015.04.007 
Marques-Vidal, P.,  Bochud, M.,  Bastardot, F.,  Luscher, T.,  Ferrero, F.,  Gaspoz, J. M.,  Paccaud, F.,  
Urwyler, A.,  von Kanel, R.,  Hock, C.,  Waeber, G.,  Preisig, M., Vollenweider, P. 2011. Levels and 
determinants of inflammatory biomarkers in a Swiss population-based sample (CoLaus study). 
PLoS One, 6, e21002. doi:10.1371/journal.pone.0021002 
Mattisson, C.,  Bogren, M.,  Nettelbladt, P.,  Munk-Jorgensen, P., Bhugra, D. 2005. First incidence 
depression in the Lundby Study: a comparison of the two time periods 1947-1972 and 1972-
1997. J Affect Disord, 87, 151-160. doi:10.1016/j.jad.2005.04.002 
Mezuk, B.,  Eaton, W. W.,  Albrecht, S., Golden, S. H. 2008. Depression and type 2 diabetes over the 
lifespan: a meta-analysis. Diabetes Care, 31, 2383-2390. doi:10.2337/dc08-0985 
Milaneschi, Y.,  Lamers, F.,  Peyrot, W. J.,  Abdellaoui, A.,  Willemsen, G.,  Hottenga, J. J.,  Jansen, R.,  
Mbarek, H.,  Dehghan, A.,  Lu, C.,  group, C. i. w.,  Boomsma, D. I., Penninx, B. W. 2015. Polygenic 
dissection of major depression clinical heterogeneity. Mol Psychiatry. doi:10.1038/mp.2015.86 
Murphy, J. M.,  Nierenberg, A. A.,  Laird, N. M.,  Monson, R. R.,  Sobol, A. M., Leighton, A. H. 2002. 
Incidence of major depression: prediction from subthreshold categories in the Stirling County 
Study. J Affect Disord, 68, 251-259.  
Nouwen, A.,  Winkley, K.,  Twisk, J.,  Lloyd, C. E.,  Peyrot, M.,  Ismail, K.,  Pouwer, F., European Depression 
in Diabetes Research, C. 2010. Type 2 diabetes mellitus as a risk factor for the onset of 
depression: a systematic review and meta-analysis. Diabetologia, 53, 2480-2486. 
doi:10.1007/s00125-010-1874-x 
Nurnberger, J. I., Jr.,  Blehar, M. C.,  Kaufmann, C. A.,  York-Cooler, C.,  Simpson, S. G.,  Harkavy-Friedman, 
J.,  Severe, J. B.,  Malaspina, D., Reich, T. 1994. Diagnostic interview for genetic studies. 
Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry, 51, 849-
859; discussion 863-844.  
Ormel, J.,  Oldehinkel, A. J., Vollebergh, W. 2004. Vulnerability before, during, and after a major 
depressive episode: a 3-wave population-based study. Arch Gen Psychiatry, 61, 990-996. 
doi:10.1001/archpsyc.61.10.990 
Palsson, S. P.,  Ostling, S., Skoog, I. 2001. The incidence of first-onset depression in a population followed 
from the age of 70 to 85. Psychol Med, 31, 1159-1168.  
Pan, A.,  Keum, N.,  Okereke, O. I.,  Sun, Q.,  Kivimaki, M.,  Rubin, R. R., Hu, F. B. 2012. Bidirectional 
association between depression and metabolic syndrome: a systematic review and meta-analysis 
of epidemiological studies. Diabetes Care, 35, 1171-1180. doi:10.2337/dc11-2055 
Pasco, J. A.,  Nicholson, G. C.,  Williams, L. J.,  Jacka, F. N.,  Henry, M. J.,  Kotowicz, M. A.,  Schneider, H. 
G.,  Leonard, B. E., Berk, M. 2010. Association of high-sensitivity C-reactive protein with de novo 
major depression. Br J Psychiatry, 197, 372-377. doi:10.1192/bjp.bp.109.076430 
Penninx, B. W.,  Milaneschi, Y.,  Lamers, F., Vogelzangs, N. 2013. Understanding the somatic 
consequences of depression: biological mechanisms and the role of depression symptom profile. 
BMC Med, 11, 129. doi:10.1186/1741-7015-11-129 
Perrin, M.,  Vandeleur, C. L.,  Castelao, E.,  Rothen, S.,  Glaus, J.,  Vollenweider, P., Preisig, M. 2014. 
Determinants of the development of post-traumatic stress disorder, in the general population. 
Soc Psychiatry Psychiatr Epidemiol, 49, 447-457. doi:10.1007/s00127-013-0762-3 
Piccinelli, M., Wilkinson, G. 2000. Gender differences in depression. Critical review. Br J Psychiatry, 177, 
486-492.  
Preisig, M.,  Fenton, B. T.,  Matthey, M. L.,  Berney, A., Ferrero, F. 1999. Diagnostic interview for genetic 
studies (DIGS): inter-rater and test-retest reliability of the French version. Eur Arch Psychiatry 
Clin Neurosci, 249, 174-179.  
Preisig, M.,  Waeber, G.,  Vollenweider, P.,  Bovet, P.,  Rothen, S.,  Vandeleur, C.,  Guex, P.,  Middleton, L.,  
Waterworth, D.,  Mooser, V.,  Tozzi, F., Muglia, P. 2009. The PsyCoLaus study: methodology and 
characteristics of the sample of a population-based survey on psychiatric disorders and their 
association with genetic and cardiovascular risk factors. BMC Psychiatry, 9, 9. doi:10.1186/1471-
244X-9-9 
Ridker, P. M. 2016. From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To 
Identify Novel Targets for Atheroprotection. Circ Res, 118, 145-156. 
doi:10.1161/CIRCRESAHA.115.306656 
Rothermundt, M.,  Arolt, V.,  Fenker, J.,  Gutbrodt, H.,  Peters, M., Kirchner, H. 2001. Different immune 
patterns in melancholic and non-melancholic major depression. Eur Arch Psychiatry Clin 
Neurosci, 251, 90-97.  
Smith, D. J.,  Escott-Price, V.,  Davies, G.,  Bailey, M. E.,  Colodro-Conde, L.,  Ward, J.,  Vedernikov, A.,  
Marioni, R.,  Cullen, B.,  Lyall, D.,  Hagenaars, S. P.,  Liewald, D. C.,  Luciano, M.,  Gale, C. R.,  
Ritchie, S. J.,  Hayward, C.,  Nicholl, B.,  Bulik-Sullivan, B.,  Adams, M.,  Couvy-Duchesne, B.,  
Graham, N.,  Mackay, D.,  Evans, J.,  Smith, B. H.,  Porteous, D. J.,  Medland, S. E.,  Martin, N. G.,  
Holmans, P.,  McIntosh, A. M.,  Pell, J. P.,  Deary, I. J., O'Donovan, M. C. 2016. Genome-wide 
analysis of over 106 000 individuals identifies 9 neuroticism-associated loci. Mol Psychiatry, 21, 
1644. doi:10.1038/mp.2016.177 
Sullivan, P. F.,  Prescott, C. A., Kendler, K. S. 2002. The subtypes of major depression in a twin registry. J 
Affect Disord, 68, 273-284.  
Takeuchi, T.,  Nakao, M.,  Kachi, Y., Yano, E. 2013. Association of metabolic syndrome with atypical 
features of depression in Japanese people. Psychiatry Clin Neurosci, 67, 532-539. 
doi:10.1111/pcn.12104 
Valkanova, V., Ebmeier, K. P. 2013. Vascular risk factors and depression in later life: a systematic review 
and meta-analysis. Biol Psychiatry, 73, 406-413. doi:10.1016/j.biopsych.2012.10.028 
Vandeleur, C. L.,  Rothen, S.,  Lustenberger, Y.,  Glaus, J.,  Castelao, E., Preisig, M. 2015. Inter-informant 
agreement and prevalence estimates for mood syndromes: direct interview vs. family history 
method. J Affect Disord, 171, 120-127. doi:10.1016/j.jad.2014.08.048 
Vinberg, M.,  Miskowiak, K., Kessing, L. V. 2013. Risk markers for affective disorder, a seven-years follow 
up study of a twin cohort at low and high risk for affective disorder. J Psychiatr Res, 47, 565-571. 
doi:10.1016/j.jpsychires.2013.01.013 
Vogelzangs, N.,  Comijs, H. C.,  Oude Voshaar, R. C.,  Stek, M. L., Penninx, B. W. 2014. Late-life depression 
symptom profiles are differentially associated with immunometabolic functioning. Brain Behav 
Immun, 41, 109-115. doi:10.1016/j.bbi.2014.05.004 
Wang, J.,  Williams, J.,  Lavorato, D.,  Schmitz, N.,  Dewa, C., Patten, S. B. 2010. The incidence of major 
depression in Canada: the National Population Health Survey. J Affect Disord, 123, 158-163. 
doi:10.1016/j.jad.2009.07.016 
Whisman, M. A., Bruce, M. L. 1999. Marital dissatisfaction and incidence of major depressive episode in a 
community sample. J Abnorm Psychol, 108, 674-678.  
Wilde, A.,  Chan, H. N.,  Rahman, B.,  Meiser, B.,  Mitchell, P. B.,  Schofield, P. R., Green, M. J. 2014. A 
meta-analysis of the risk of major affective disorder in relatives of individuals affected by major 
depressive disorder or bipolar disorder. J Affect Disord, 158, 37-47. 
doi:10.1016/j.jad.2014.01.014 
Wium-Andersen, M. K.,  Orsted, D. D., Nordestgaard, B. G. 2014. Elevated C-reactive protein, depression, 
somatic diseases, and all-cause mortality: a mendelian randomization study. Biol Psychiatry, 76, 
249-257. doi:10.1016/j.biopsych.2013.10.009 
 
